BeStock  
Stocks › Biotechnology › MNKD

MannKind MNKD

US equityMarket cap rank #3020Biotechnology
$3.85 −$0.10 (-2.53%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $3.93 +2.08%
Open$3.90
Prev close$3.95
Day range$3.83 – $4.08
Volume4.18M
Market cap$1.24B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$101.87M+24.0% YoY
Operating profit-$2.57M-113.7% YoY
Net profit-$23.22M-390.8% YoY
Diluted EPS-$0.07-333.3% YoY
Free cash flow-$37.76M-267.7% YoY
Operating cash flow-$34.55M

Revenue, last 8 quarters

$76.8MDec '24$78.4MMar '25$76.5MJun '25$82.1MSep '25$112.0MDec '25$90.2MMar '26$109.4MJun '26$101.9MSep '26

Net profit, last 8 quarters

$7.4MDec '24$13.2MMar '25$668.0KJun '25$8.0MSep '25$-15.9MDec '25$-16.6MMar '26$-19.0MJun '26$-23.2MSep '26

Diluted EPS by quarter

0.03Dec '240.04Mar '250.00Jun '250.03Sep '25-0.05Dec '25-0.05Mar '26-0.06Jun '26-0.07Sep '26

Free cash flow by quarter

$19.7MDec '24$-6.7MMar '25$7.8MJun '25$22.5MSep '25$-10.0MDec '25$-7.2MMar '26$-23.5MJun '26$-37.8MSep '26

Annual revenue

$65.1MFY20$75.4MFY21$99.8MFY22$199.0MFY23$285.5MFY24$349.0MFY25

Profitability & balance sheet

Gross margin75.8%
Operating margin-3.4%
Net margin-18.1%
Return on assets-12.3%
Current ratio2.22
Liabilities / assets105.2%
Cash & investments$96.61M
Total debt$328.62M
Net cash (debt)-$232.02M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $101.87M $109.37M $90.17M $348.97M $111.96M
Total Operating Revenue $101.87M $109.38M $90.17M $348.97M $111.96M
Cost of Revenue $23.51M $29.54M $17.47M $87.96M $29.67M
Gross Profit $78.36M $79.84M $72.70M $261.01M $82.28M
Operating Expense $80.93M $80.67M $75.68M $214.46M $89.97M
Selling and Admin Expenses $61.41M $58.30M $54.09M $144.14M $58.41M
Research & Development $14.36M $18.00M $17.23M $66.35M $27.59M
Depreciation & Amortization & Depletion $5.16M $4.37M $4.37M $3.97M –
-Depreciation & Amortization $5.16M $4.37M $4.37M $3.97M –
Operating Profit -$2.57M -$835,000.00 -$2.99M $46.55M -$7.69M
Net Non-Operating Interest Income (Expense) -$9.49M -$13.80M -$11.01M -$29.98M -$12.24M
Non-Operating Interest Income $1.09M $1.02M $1.43M $8.05M $1.64M
Non-Operating Interest Expense $10.58M $14.77M $12.38M $37.82M $13.67M
Other Income (Expense) -$11.11M -$4.51M -$2.38M -$15.17M -$1.01M
Gain on Sale of Security $391,000.00 $486,000.00 $1.32M -$7.75M $3,000.00
Special Income (Charges) $0.00 $0.00 -$917,000.00 -$6.41M $0.00
-Less:Write Off $0.00 – – $6.41M $0.00
Other Non-Operating Income (Expenses) -$11.50M -$4.99M -$2.78M -$1.01M –
Pretax Profit -$23.17M -$19.14M -$16.37M $1.41M -$20.93M
Tax $51,000.00 -$106,000.00 $253,000.00 -$4.46M -$4.98M
Net Profit -$23.22M -$19.03M -$16.62M $5.86M -$15.95M
Profit from Continuing Operations -$23.22M -$19.03M -$16.62M $5.86M -$15.95M
Net Income to Parent Company -$23.22M -$19.03M -$16.62M $5.86M -$15.95M
Net Income to Common Stockholders -$23.22M -$19.03M -$16.62M $5.86M -$15.95M
Basic EPS -$0.07 -$0.06 -$0.05 $0.02 -$0.05
Diluted EPS -$0.07 -$0.06 -$0.05 $0.02 -$0.05
Total Other Finance Costs – $52,000.00 $51,000.00 $207,000.00 –
-Less:Other Special Charges – – $917,000.00 – –
-Less:Restructuring and Mergern & Acquisition – – – $0.00 $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $722.62M $732.30M $744.40M $792.18M $792.18M
Total Current Assets $240.48M $245.71M $251.16M $291.58M $291.58M
Cash and Cash Equivalents & Short-Term Investments $96.61M $111.13M $133.86M $171.35M $171.35M
-Cash and Cash Equivalents $41.28M $52.93M $52.83M $74.88M $74.88M
-Short Term Investments $55.33M $58.20M $81.03M $96.46M $96.46M
Receivables $41.03M $43.21M $28.14M $38.37M $38.37M
-Accounts Receivable $41.03M $43.21M $28.14M $38.37M $38.37M
Inventory $48.47M $44.42M $49.17M $35.31M $35.31M
Other Current Assets $54.36M $46.96M $40.00M $46.55M $46.55M
Total Non-Current Assets $482.14M $486.59M $493.24M $500.60M $500.60M
Net PPE $86.37M $85.16M $82.55M $82.42M $82.42M
-Gross PPE $206.27M $202.98M $198.35M $196.34M $196.34M
-Accumulated Depreciation -$119.90M -$117.82M -$115.79M -$113.91M -$113.91M
Investments and Advances $0.00 $0.00 $0.00 $5.01M $5.01M
Goodwill and Other Intangible Assets $378.40M $383.56M $387.93M $392.29M $392.29M
-Goodwill $67.60M $67.60M $67.60M $67.60M $67.60M
-Other Intangible Assets $310.80M $315.97M $320.33M $324.70M $324.70M
Other Non-Current Assets $17.37M $17.87M $22.76M $20.87M $20.87M
Total Liabilities $759.88M $799.50M $803.60M $843.20M $843.20M
Total Current Liabilities $108.52M $142.90M $134.56M $171.03M $171.03M
Payables $14.38M $11.04M $16.14M $9.03M $9.03M
-Accounts Payable $14.38M $11.04M $16.14M $9.03M $9.03M
Current Accrued Expenses $55.91M $57.38M $53.62M $56.69M $56.69M
Short-Term Debt and Capital Lease Obligation $2.10M $2.08M $1.96M $38.39M $38.39M
-Current Capital Lease Obligation $2.10M $2.08M $1.96M $2.11M $2.11M
Current Deferred Liabilities $9.41M $11.09M $11.53M $15.33M $15.33M
Other Current Liabilities $26.72M $61.03M $51.07M $51.29M $51.29M
Total Non-Current Liabilities $651.36M $656.60M $669.04M $672.17M $672.17M
Long Term Debt and Capital Lease Obligation $328.62M $328.77M $329.00M $329.05M $329.05M
-Long Term Debt $319.45M $319.09M $318.72M $318.36M $318.36M
-Long Term Capital Lease Obligation $9.18M $9.69M $10.28M $10.69M $10.69M
Non-Current Deferred Liabilities $34.81M $36.86M $38.91M $39.98M $39.98M
Other Non-Current Liabilities $287.93M $290.97M $301.13M $303.15M $303.15M
Total Equity -$37.27M -$67.20M -$59.20M -$51.02M -$51.02M
Stockholders' Equity -$37.27M -$67.20M -$59.20M -$51.02M -$51.02M
Capital Stock $3.22M $3.10M $3.09M $3.08M $3.08M
-Common Stock $3.22M $3.10M $3.09M $3.08M $3.08M
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $3.21B $3.16B $3.15B $3.14B $3.14B
Retained Earnings -$3.25B -$3.23B -$3.21B -$3.20B -$3.20B
Gains/Losses Not Affecting Retained Earnings -$88,000.00 -$19,000.00 -$4,000.00 $115,000.00 $115,000.00
Current Provisions – $290,000.00 $240,000.00 $291,000.00 $291,000.00
-Available for Sale Securities – – – $5.01M $5.01M
-Current Debt – – – $36.28M $36.28M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$34.55M -$18.37M -$5.37M $18.26M -$7.96M
Net cash flow from continuing operations -$34.55M -$18.37M -$5.37M $18.26M -$7.96M
Net Income from Continuing Operations -$23.22M -$19.03M -$16.62M $5.86M -$15.95M
Gain/Loss from Continuing Operations -$391,000.00 -$486,000.00 -$401,000.00 $14.16M -$3,000.00
Depreciation & Depletion & Amortization $7.68M $6.84M $6.91M $12.28M $4.22M
Other Non-Cash Items $7.92M $2.68M $2.46M $4.89M $3.40M
Change in Working Capital -$33.42M -$19.79M -$4.98M -$50.88M -$8.26M
-Change in Receivables $2.17M -$15.07M $10.29M -$4.76M $817,000.00
-Change in Inventory -$4.65M $3.38M -$14.93M -$6.62M $797,000.00
-Change in Prepaid Assets -$7.41M -$6.96M $6.56M -$10.03M $2.33M
-Change in Payables and Accrued Expense $2.86M -$2.29M $1.34M -$18.42M -$8.81M
-Change in Other Current Assets $52,000.00 $4.45M -$2.42M -$1.91M -$383,000.00
-Change in Other Current Liabilities -$22.72M -$806,000.00 -$939,000.00 -$873,000.00 $0.00
-Change In Other Working Capital -$3.72M -$2.49M -$4.88M -$8.26M -$3.01M
Net cash flow from investing -$252,000.00 $17.91M $18.73M -$304.80M -$291.96M
Net Cash Flow from Continuing Investing Activities -$252,000.00 $17.91M $18.73M -$304.80M -$291.96M
Net PPE Purchase and Sale -$3.21M -$5.08M -$1.88M -$4.57M -$1.99M
Net Investment Purchase and Sale $2.96M $22.99M $20.61M $57.51M $57.77M
Financing Cash Flow $23.15M $559,000.00 -$35.41M $315.10M $247.41M
Net Cash Flow from Continuing Financing Activities $23.15M $559,000.00 -$35.41M $315.10M $247.41M
Net Issuance Payments Of Debt $0.00 $0.00 -$35.50M $325.00M $250.00M
Proceeds from Stock Option Exercised $0.00 $1.64M $270,000.00 $1.99M $654,000.00
Net Other Financing Charges -$22.91M -$978,000.00 -$279,000.00 -$11.89M -$8.38M
Ending Cash Balance $42.03M $53.68M $53.58M $75.63M $75.63M
Net Change in Cash -$11.65M $97,000.00 -$22.05M $28.55M -$52.51M
Beginning Cash Balance $53.68M $53.58M $75.63M $47.08M $128.14M
Free Cash Flow -$37.76M -$23.45M -$7.25M $13.69M -$9.95M
Net Common Stock Issuance – – $105,000.00 $0.00 $5.14M
Net Business Purchase and Sale – – – -$347.74M –
Net Other Investing Changes – – – -$10.00M $0.00

Discussion

No comments yet — be the first to weigh in on MNKD.

Sign in to join the discussion.

Scroll to Top